DOUGLAS GRUENBACHER: Open Payments
NPI 1376597872 · QUINTER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 12 payments from 8 companies in 2025. Trend: 2023 $168 · 2024 $413 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $58 |
| Lilly USA, LLC | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Amgen Inc. | 2 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| MIMEDX Group, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
Products named: Ozempic, MOUNJARO, EVKEEZA, EVENITY, LEQVIO, Rybelsus, DEXCOM G7 GSS (161), VRAYLAR.
Industry payments across KS — which companies pay providers there.
